Brussels, 12 June 2019 - Euronext today announced the results of the quarterly review for the BEL 20®, BEL Mid®, and BEL Small® indices. The changes due to the review will be effective from Monday 24 June 2019.
Results of the June 2019 Review:
BEL 20®
Inclusion of: | Exclusion of: |
---|---|
None | None |
BEL Mid®
Inclusion of: | Exclusion of: |
---|---|
Atenor | None |
BEL Small®
Inclusion of: | Exclusion of: |
---|---|
Sequana Medical |
Atenor |
FNG NV |
The compiler retains the right to change the published selection, for instance in case of a removal due to a take-over, till the publication of the final data after close of Wednesday 19 June 2019. All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.
Review BEL 20®, BEL Mid® and BEL Small®
The BEL 20®, BEL Mid® and BEL Small® are reviewed quarterly in June, September and December. The full annual review is in March. The quarterly reviews serve to replace removed constituents and to facilitate inclusion of recently listed companies.
MEDIA CONTACTS
Pascal Brabant: +32 2 620 15 50; pbrabant@euronext.com